81 related articles for article (PubMed ID: 14761279)
1. [A study on the mutation of P gene region including YMDD motif in hepatitis B virus].
Feng B; Wei L; Chen M; Li XH
Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):29-31. PubMed ID: 14761279
[TBL] [Abstract][Full Text] [Related]
2. [Dynamic variations of hepatitis B virus polymerase gene in lamivudine-treated hepatitis B patients].
Feng B; Wei L; Chen M; Han FZ; Wang LP
Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):327-30. PubMed ID: 16732904
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B.
Feng B; Wei L; Chen M; Wang L
Microbiol Res; 2008; 163(4):487-92. PubMed ID: 17317127
[TBL] [Abstract][Full Text] [Related]
4. [Detection and analysis of the new kind of G743C and G743A point mutation of HBV P gene in hepatitis B virus infected patients resistant to lamivudine].
Pan XP; Wo JE; Chen Z; Chen F; Liang WF; Liu KZ
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):616-8. PubMed ID: 14572341
[TBL] [Abstract][Full Text] [Related]
5. [Natural YMDD motif mutations of HBV polymerase in the chronic hepatitis B virus infected patients].
Shin YM; Heo J; Kim GH; Kang DH; Song GA; Cho M; Yang US; Kim CM; Park HK; Jang HJ
Taehan Kan Hakhoe Chi; 2003 Mar; 9(1):1-9. PubMed ID: 12657823
[TBL] [Abstract][Full Text] [Related]
6. YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine.
Matsuda M; Suzuki F; Suzuki Y; Tsubota A; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Satoh J; Kobayashi M; Ikeda K; Miyakawa Y; Kumada H
J Med Virol; 2004 Oct; 74(2):361-6. PubMed ID: 15332287
[TBL] [Abstract][Full Text] [Related]
7. Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping.
Ohishi W; Shirakawa H; Kawakami Y; Kimura S; Kamiyasu M; Tazuma S; Nakanishi T; Chayama K
J Med Virol; 2004 Apr; 72(4):558-65. PubMed ID: 14981758
[TBL] [Abstract][Full Text] [Related]
8. PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine.
Yang DH; Liang WF; Xie YJ; Zhao NF; Fan J
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):232-7. PubMed ID: 14612274
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine.
Amini-Bavil-Olyaee S; Hosseini SY; Sabahi F; Alavian SM
Int J Infect Dis; 2008 Jan; 12(1):83-7. PubMed ID: 17698384
[TBL] [Abstract][Full Text] [Related]
10. Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection.
Ramezani A; Velayati AA; Roshan MR; Gachkar L; Banifazl M; Keyvani H; Aghakhani A
Int J Infect Dis; 2008 May; 12(3):252-5. PubMed ID: 17954033
[TBL] [Abstract][Full Text] [Related]
11. Detection of the YMDD motif mutation of P gene of hepatitis B virus using polymerase chain reaction-restriction fragment length polymorphism.
Zhou ZY; Sun J; Chen JJ; Hou JL; Luo KX
Di Yi Jun Yi Da Xue Xue Bao; 2001; 21(12):885-887. PubMed ID: 12426155
[TBL] [Abstract][Full Text] [Related]
12. [A study on detection method of lamivudine related mutations in hepatitis B virus polymerase gene].
Ding JJ; Zhang WS; Zhang LS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):24-7. PubMed ID: 15340520
[TBL] [Abstract][Full Text] [Related]
13. Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine.
Matsuda M; Suzuki F; Suzuki Y; Tsubota A; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Satoh J; Takagi K; Kobayashi M; Ikeda K; Kumada H
J Gastroenterol; 2004 Jan; 39(1):34-40. PubMed ID: 14767732
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation].
Deng H; Lv Y; Fu J
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):368-9. PubMed ID: 15225437
[TBL] [Abstract][Full Text] [Related]
15. [Study of gene chips in the detection of YMDD mutations in the region of HBV polymeras].
Zhang XH; Zhang YX; Sun LR; Wen Q; Zhou LQ; Fan GX; Zhang X; Yang DG
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):459-62. PubMed ID: 12887756
[TBL] [Abstract][Full Text] [Related]
16. [Detection of the mutation in HBV polymerase gene by RFLP PCR method in hepatitis B patients treated with lamivudine].
Li Z; Guo YB; Hao W; Lin ZH; Jin HY; Liu DG
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):266-9. PubMed ID: 15340574
[TBL] [Abstract][Full Text] [Related]
17. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
Paik YH; Han KH; Hong SP; Lee HW; Lee KS; Kim SO; Shin JE; Ahn SH; Chon CY; Moon YM
Antivir Ther; 2006; 11(4):447-55. PubMed ID: 16856618
[TBL] [Abstract][Full Text] [Related]
18. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.
Akarsu M; Sengonul A; Tankurt E; Sayiner AA; Topalak O; Akpinar H; Abacioglu YH
J Gastroenterol Hepatol; 2006 Dec; 21(12):1783-8. PubMed ID: 17074014
[TBL] [Abstract][Full Text] [Related]
19. [Detection of YMDD mutations in hepatitis B virus DNA with the use of allele specific polymerase chain reaction].
Pichkovskaia VA; Fevraleva IS; Ibragimova MM; Solov'eva TI; Drel' PE; Sudarikov AB
Mol Gen Mikrobiol Virusol; 2004; (1):27-9. PubMed ID: 15025001
[TBL] [Abstract][Full Text] [Related]
20. [Detection and identification of emergence of HBV YMDD motif mutation during lamivudine treatment by hybridization to an oligonucleotide array].
Zhao W; Liu W; Liu QJ; Zhang L; Zhang HR; Liu XJ; Zhou ZX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Dec; 17(4):339-43. PubMed ID: 15340547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
